Decreased base excision repair and increased helicase activity in Alzheimer's disease brain

Brain Research

Volumn 855, Issue 1, 2000, Pages 116-123

  Lovell, Mark A ^a   Xie, Chengsong ^a   Markesbery, William R ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Base excision repair; DNA oxidation; DNA repair; Helicases

Indexed keywords

HELICASE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; EXCISION REPAIR; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PARIETAL LOBE; PRIORITY JOURNAL; SUBICULUM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CELL FRACTIONATION; CELL NUCLEUS; DNA; DNA HELICASES; DNA REPAIR; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; FEMALE; HUMANS; MALE; N-GLYCOSYL HYDROLASES; OXIDATION-REDUCTION;

EID: 0033984570     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02335-5     Document Type: Article

References (81)

1. Adelman R., Saul R.L., Ames B.N. Oxidative damage to DNA: relation to species metabolic rate and life span. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2706-2708.
2. Ames B.N. Endogenous oxidative DNA damage, aging, and cancer. Free Radical Res. Commun. 7:1989;121-128.
3. Anderson C.T., Friedberg E.C. The presence of nuclear and mitochondrial uracil-DNA glycosylase in extracts of human KB cells. Nucleic Acids Res. 8:1980;875-888.
4. Arthur H.M., Eastlake P.B. Transcriptional control of the uvrD gene of Escherichia coli. Gene. 25:1983;309-316.
5. Bartram C.R. DNA repair: pathways and defects. Eur. J. Pediatr. 135:1980;121-128.
6. C. Bernstein, H. Bernstein, Aging, Sex, and DNA Repair, Academic Press, San Diego, CA, 1991.
7. Bessho T., Tano K., Kasai H., Nishimura S. Deficiency of 8-hydroxyguanine DNA endonuclease activity and accumulation of the 8-hydroxyguanine in mutator mutant (MutM) of Escherichia coli. Biochem. Biophys. Res. Commun. 188:1992;372-378.
8. Boerrigter M.E., Vijg J. Studies on DNA repair defects in degenerative brain disease. Age Aging. 22:1993;S44-S52.
9. Bozner P., Grishk V., LeDoux S.P., Wilson G.L., Chyan Y.C., Pappolla M.A. The amyloid beta protein induces oxidative damage of mitochondrial DNA. J. Neuropathol. Exp. Neurol. 56:1997;1356-1362.
10. H. Braak, E. Braak, Pathology of Alzheimer's disease, in: D.B. Calne (Ed.), Neurodegenerative Disease, W.B. Saunders, Philadelphia, PA, 1994, pp. 585-613.
11. Caron P.R., Kushner S.R., Grossman L. Involvement of helicase II (uvrD gene product) and DNA polymerase I in excision mediated by the uvrABC protein complex. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4925-4929.
12. Chung M.-H., Kasai H., Jones D.S., Inoue H., Ishikawa H., Ohtsuka E., Nishimura S. An endonuclease activity of Escherichia coli that specifically removes 8-hydroxyguanine residues from DNA. Mutat. Res. 254:1991;1-12.
13. Chung M.-H., Kim H.-S., Ohtsuka E., Kasai H., Yamamoto F., Nishimura S. An endonuclease activity in human polymorphonuclear neutrophils that removes 8-hydroxyguanine residues from DNA. Biochem. Biophys. Res. Commun. 178:1991;1472-1478.
14. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275:1992;331-342.
15. Dodson M.L., Schrock R.D. III, Lloyd R.S. Evidence for an imino intermediate in the T4 endonuclease V reaction. Biochemistry. 32:1993;8284-8290.
16. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell. 83:1995;655-666.
17. Fraga C.G., Shigenaga M.K., Park J.W., Degan P., Ames B.N. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. U.S.A. 87:1990;4533-4537.
18. E.C. Friedberg, R.D. Wood, DNA excision repair pathways, in: M.L. De Pamphilis (Ed.), DNA Replication in Eukaryotic Cells, Cold Spring Harbor Laboratory Press, Plainview, New York, 1996, pp. 249-269.
19. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71:1998;2034-2040.
20. Gajewski E., Rao G., Nackerdien Z., Dizdaroglu M. Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry. 29:1990;7876-7882.
21. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
22. Hazra T.K., Izumi T., Maidt L., Floyd R.A., Mitra S. The presence of two distinct 8-oxoguanine repair enzymes in human cells: their potential complementary roles in preventing mutation. Nucleic Acids Res. 26:1998;5116-5122.
23. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
24. Hermon M., Cairns N., Egly J.M., Fery A., Labudova O., Lubec G. Expression of DNA excision repair cross-complementing proteins p80 and p89 in brain of patients with Down's syndrome and Alzheimer's disease. Neurosci. Lett. 251:1998;45-48.
25. Husain I., van Houten B., Thomas D.C., Abdel-Monem M., Sancar A. Effect of DNA polymerase I and DNA helicase II on the turnover rate of UvrABC excision nuclease. Proc. Natl. Acad. Sci. U.S.A. 82:1985;6774-6778.
26. Hyman B.T., Tanzi R.E., Marzloff K., Barbour R., Schenk D.D. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 51:1992;76-83.
27. Jones S.K., Nee L.E., Sweet L., Polinsky R.J., Bartlett J.D., Bradley W.G., Robison S.H. Decreased DNA repair in familial Alzheimer's disease. Mutat. Res. 219:1989;247-255.
28. Kamiya H., Murata-Kamiya N., Fujimuro M., Kido K., Inoue H., Hishimura S., Masutani C., Hanaoka F., Ohtsuka E. Comparison of incorporation and extension of nucleotides in vitro opposite 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene. Jpn. J. Cancer Res. 86:1995;270-276.
29. H.N. Kasai, S. Nishimura, in: H. Sies (Ed.), Oxidative Stress and Antioxidants, Academic Press, London, 1991, pp. 96-116.
30. Korn R., Ramkisson Y. Bloom's syndrome. Mapping to the point. Nature. 378:1995;557-580.
31. Kuchino Y., Mori F., Kasai H., Inoue H., Iwai S., Miura K., Ohtsuka E., Nishimura S. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature. 327:1987;77-79.
32. K. Kumura, K. Oeda, M. Akiyama, T. Horiuchi, M. Sekiguch, in: E.C. Friedberg, B.A. Bridges (Eds.), Cellular Responses to DNA Damage, Liss, New York, 1983, pp. 51-62.
33. Kumura K., Sekiguchi M. Identification of the uvrD gene product of Escherichia coli as DNA helicase II and its induction by DNA-damaging agents. J. Biol. Chem. 259:1984;1560-1565.
34. Lahue R.S., Au K.G., Modrich P. DNA mismatch correction in a defined system. Science. 245:1989;160-164.
35. Li J.C., Kaminskas E. Deficient repair of DNA lesions in Alzheimer's disease fibroblasts. Biochem. Biophys. Res. Commun. 129:1985;733-738.
36. Loft S., Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74:1996;297-312.
37. Lohman T.M., Chao K., Green J.M., Sage S., Runyon G.T. Large-scale purification and characterization of the Escherichia coli rep gene product. J. Biol. Chem. 264:1989;10139-10147.
38. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
39. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
40. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72:1999;771-776.
41. Lu R., Nash H.M., Verdine G.L. Mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to locus frequently lost in lung cancer. Curr. Biol. 7:1997;397-407.
42. Lyras L., Cairns N.J., Jenner P., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68:1997;2061-2069.
43. Maples V.F., Kushner S.R. DNA repair in Escherichia coli: identification of the uvrD gene product. Proc. Natl. Acad. Sci. U.S.A. 79:1982;5616-5620.
44. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
45. Matson S.W., Kaiser-Rogers K.A. DNA helicases. Annu. Rev. Biochem. 59:1990;289-329.
46. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
47. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
48. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
49. Montine K.S., Olson S.J., Amarnath V., Whetsell W.O., Graham D.G., Montine T.J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150:1997;437-443.
50. 2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44:1998;410-413.
51. Mullaart E., Boerrigter M.E., Ravid R., Swaab D.F., Vijg J. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol. Aging. 11:1990;169-173.
52. Nakayama K., Irino M., Nakayama H. recA+gene-dependent regulation of a uvrDlacZ fusion in Escherichia coli K12. Mol. Gen. Genet. 192:1983;391-394.
53. Nash H.M., Bruner S.D., Scharer O.D., Kawate T., Addona T.A., Sponner E., Lane W.S., Verdine G.L. Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision of a base excision DNA-repair protein superfamily. Curr. Biol. 6:1996;968-980.
54. National Institute on Aging, and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 18:1997;S1-S2.
55. Oeda K., Horiuchi T., Sekiguchi M. Molecular cloning of the uvrD gene of Escherichia coli that controls ultraviolet sensitivity and spontaneous mutation frequency. Mol. Gen. Genet. 184:1981;191-199.
56. Pappolla M.A., Omar R.A., Kim K.S., Robakis N.K. Immunochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
57. Peterson S.N., Schramm N., Hu P.C., Bott K.F., Hutchison C.A. A random sequencing approach for placing markers on the physical map of Mycoplasma genitalium. Nucleic Acids Res. 19:1991;6027-6031.
58. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:1998;81-83.
59. Robbins J.H., Otsuka F., Tarone R.E., Polinsky R., Brumback R.A., Moshell A.N., Nee L.E., Ganges M.B., Cayeux S.J. Radiosensitivity in Alzheimer's disease and Parkinson's disease. Lancet. 1:1983;469-469.
60. Robbins J.H., Brumback R.A., Polinsky R.J., Wirtschafter J.D., Tarone R.E., Scudiero D.A., Otsuka F. Hypersensitivity to DNA-damaging agents in abiotrophies: a new explanation for degeneration of neurons, photoreceptors, and muscle in Alzheimer's, Parkinson's and Huntington's diseases, retinitis pigmentosa, and Duchenne muscular dystrophy. Basic Life Sci. 35:1985;315-344.
61. Robison S.H., Munzer J.S., Tandan R., Bradley W.G. Alzheimer's disease cells exhibit defective repair of alkylating agent-induced DNA damage. Ann. Neurol. 21:1987;250-258.
62. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
63. Scudiero D.A., Polinsky R.J., Brumback R.A., Tarone R.E., Nee L.E., Robbins J.H. Alzheimer disease fibroblasts are hypersensitive to the lethal effects of a DNA-damaging chemical. Mutat. Res. 159:1986;125-131.
64. Shen J.-C., Gray M.D., Oshima J., Loeb L.A. Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res. 26:1998;2879-2885.
65. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 349:1991;431-434.
66. Shigenaga M.K., Aboujaoude E.N., Chen Q., Ames B.N. Assays of oxidative DNA damage biomarkers 2-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 234:1994;16-33.
67. Siegel E.C. The Escherichia coli uvrD gene is inducible by DNA damage. Mol. Gen. Genet. 191:1983;397-400.
68. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10540-10543.
69. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer's disease pathology. Proc. Natl. Acad. Sci. U.S.A. 91:1994;5710-5714.
70. Smith M.A., Sayre L., Monnier V., Perry G. Radical aging in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
71. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
72. Sun B., Latham K.A., Dodson M.L., Lloyd R.S. Studies on the catalytic mechanism of five DNA glycosylases. Probing for enzyme DNA imino intermediates. J. Biol. Chem. 270:1995;19501-19508.
73. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
74. Taucher-Scholz G., Hoffmann-Berling H. Identification of the gene for DNA helicase II of Escherichia coli. Eur. J. Biochem. 137:1983;573-580.
75. Tchou J., Kasai H., Shibutani S., Chung M.-H., Laval J., Grollman A.P., Nishimura S. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4690-4694.
76. Tchou J., Grollman A.P. The catalytic mechanism of Fpg protein. Evidence for a Schiff base intermediate and amino terminus localization of the catalytic site. J. Biol. Chem. 270:1995;11671-11677.
77. Teoule R. Radiation-induced DNA damage and its repair. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 51:1987;573-589.
78. Wagner J.R., Hu C.-C., Ames B.N. Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3380-3384.
79. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J.M., Wang Z., Friedberg E.C., Evans M.K., Taffe B.G., Bohr V.A., Hoeijmakers J.H., Forrester K., Harris C.C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10:1995;188-195.
80. D.E. Wenstrup, Trace elements at the subcellular level in Alzheimer's disease, PhD dissertation, University of Kentucky, Lexington, KY, 1988.
81. Yan S.D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7787-7791.